Viracta Therapeutics Inc. Gains 37.35%
Wed, May 17, 2023 at 07:44 PM
Viracta Therapeutics Inc. (VIRX:NASDAQ) jumped higher at $1.71, a gain of 37.3%. On Wed, May 17, 2023, VIRX:NASDAQ hit a New 2-Week High of $1.71. The stock got featured on our News Catalysts scanner on Thu, May 11, 2023 at 04:44 PM in the 'MISCELLANEOUS' category. From Wed, May 03, 2023, the stock recorded 60.00% Up Days and 36.36% Green Days
About Viracta Therapeutics Inc. (VIRX:NASDAQ)
Viracta Therapeutics Inc is a clinical-stage, biomarker-directed precision oncology company focused on advancing new medicines for the treatment of virus-associated malignancies.
Top 10 Gainers:
- Aspen Group, Inc. (ASPU:NASDAQ), 179.3%
- Immutep Limited (IMMP:NASDAQ), 64.78%
- Peak Bio Inc Com (PKBO:NASDAQ), 48.12%
- National Western Life Group, Inc. (NWLI:NASDAQ), 46.32%
- Smart for Life Inc. (SMFL:NASDAQ), 44.4%
- SelectQuote Inc. (SLQT:NYSE), 41.67%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 41.09%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 38.75%
- Viracta Therapeutics Inc. (VIRX:NASDAQ), 37.35%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 36.71%